Vaxart Inc (VXRT)
0.605
-0.15
(-19.37%)
USD |
NASDAQ |
Jun 14, 13:21
Vaxart Market Cap: 106.99M for June 14, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 13, 2024 | 132.68M |
| June 12, 2024 | 134.01M |
| June 11, 2024 | 136.08M |
| June 10, 2024 | 140.66M |
| June 07, 2024 | 136.40M |
| June 06, 2024 | 141.31M |
| June 05, 2024 | 137.90M |
| June 04, 2024 | 140.94M |
| June 03, 2024 | 146.42M |
| May 31, 2024 | 144.12M |
| May 30, 2024 | 143.93M |
| May 29, 2024 | 145.36M |
| May 28, 2024 | 146.63M |
| May 24, 2024 | 153.21M |
| May 23, 2024 | 159.05M |
| May 22, 2024 | 175.67M |
| May 21, 2024 | 152.06M |
| May 20, 2024 | 158.57M |
| May 17, 2024 | 169.55M |
| May 16, 2024 | 180.37M |
| May 15, 2024 | 167.04M |
| May 14, 2024 | 152.91M |
| May 13, 2024 | 145.01M |
| May 10, 2024 | 124.67M |
| May 09, 2024 | 129.37M |
| Date | Value |
|---|---|
| May 08, 2024 | 129.09M |
| May 07, 2024 | 130.58M |
| May 06, 2024 | 135.49M |
| May 03, 2024 | 128.90M |
| May 02, 2024 | 132.45M |
| May 01, 2024 | 123.89M |
| April 30, 2024 | 126.39M |
| April 29, 2024 | 126.14M |
| April 26, 2024 | 125.50M |
| April 25, 2024 | 116.43M |
| April 24, 2024 | 125.50M |
| April 23, 2024 | 131.82M |
| April 22, 2024 | 134.84M |
| April 19, 2024 | 133.62M |
| April 18, 2024 | 148.95M |
| April 17, 2024 | 153.16M |
| April 16, 2024 | 158.16M |
| April 15, 2024 | 160.76M |
| April 12, 2024 | 160.94M |
| April 11, 2024 | 183.58M |
| April 10, 2024 | 178.29M |
| April 09, 2024 | 183.58M |
| April 08, 2024 | 190.64M |
| April 05, 2024 | 190.64M |
| April 04, 2024 | 199.47M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.657M
Minimum
Sep 26 2019
2.573B
Maximum
Feb 02 2021
403.55M
Average
207.30M
Median
Market Cap Benchmarks
| Novavax Inc | 2.114B |
| Allogene Therapeutics Inc | 492.73M |
| Inovio Pharmaceuticals Inc | 235.53M |
| Stereotaxis Inc | 153.72M |
| Arcturus Therapeutics Holdings Inc | 845.66M |
Market Cap Related Metrics
| PS Ratio | 8.586 |
| Price to Book Value | 1.921 |
| Price | 0.605 |
| Earnings Yield | -87.60% |